{"id":"W3135702916","doi":"10.1111/all.14809","title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines","year":2021,"lang":"en","type":"review","venue":"Allergy","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Horizon 2020 Framework Programme; Allergopharma; Idorsia Pharmaceuticals; Hospital for Sick Children; Sanofi; European Commission; Allergy Therapeutics; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Innovationsfonden; Teva Pharmaceutical Industries; Regeneron Pharmaceuticals; AstraZeneca; National Science Foundation","keywords":"Medicine; Nasal polyps; Mepolizumab; Omalizumab; Internal medicine; Cochrane Library; Relative risk; Adverse effect; Dupilumab; Sinusitis; Confidence interval; Chronic rhinosinusitis; Surgery; Asthma; Immunoglobulin E; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002661044,0.0004633911,0.003644337,0.00005907549,0.0001442698,0.00001820676,0.0001283214,0.0001655409,0.00006782277],"category_scores_gemma":[0.0002569591,0.0001866075,0.0005221092,0.0002349271,0.0001144408,0.00002406479,0.00003201708,0.00009028156,0.000001495171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002019858,"about_ca_system_score_gemma":0.0008713347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003846324,"about_ca_topic_score_gemma":0.00009746275,"domain_scores_codex":[0.9980273,0.0001304317,0.0009926938,0.0004387789,0.0001556531,0.0002551871],"domain_scores_gemma":[0.9967124,0.001578494,0.0006050036,0.0005835706,0.0004263145,0.00009420317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001833244,0.0001439845,9.387238e-7,0.8870144,0.006683844,0.00003836208,0.00002350076,0.000001193784,7.638303e-7,0.0007106493,0.00305922,0.1021398],"study_design_scores_gemma":[0.001995671,0.003385584,0.000005209208,0.5414839,0.009603873,0.001126511,0.00001746611,0.000006116414,5.154221e-7,0.000001044465,0.4421758,0.0001983151],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008648382,0.9880889,0.000411929,0.000348765,0.00004261761,0.01039698,0.0006367146,0.00002491115,0.000040518],"genre_scores_gemma":[0.00002271726,0.993277,0.000999048,0.0003659736,0.0002070926,0.003288059,0.001136929,0.00005654698,0.0006466096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4391166,"threshold_uncertainty_score":0.7609634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0920092648072491,"score_gpt":0.3819486176143602,"score_spread":0.2899393528071111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}